It has been reported that TRIP-Brs were associated in regulating immune-infiltrating cells, such as macrophages, CD4+ T cells, CD8+ T cells, and DCs, as well as neutrophil cells in patients with BRCA. This evidence concerns the gene CD8A and invasive breast carcinoma.